Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin A Røder

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Prostate|June 9, 2015
The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapyKasper D Berg, Martin A Røder, Frederik B Thomsen, et al.
BJU International|January 30, 2016
The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysisKasper D Berg, Frederik B Thomsen, Camilla Nerstrøm, et al.
Urology|November 28, 2021
Long-Term Renal Function Following Radical Cystectomy for Bladder CancerMaja Vejlgaard, Sophia L Maibom, Hein V Stroomberg, et al.
Biomarkers in Medicine|January 15, 2016
Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early resultsSolvej Lippert, Kasper D Berg, Gunilla Høyer-Hansen, et al.
Cancer|May 4, 2018
Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohortsJohn T Helgstrand, Martin A Røder, Nina Klemann, et al.
Cancers|April 3, 2021
Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic ResistanceThiago S Lima, Diego Iglesias-Gato, Luciano D O Souza, et al.
Frontiers in Pharmacology|June 20, 2022
Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate CancerThiago S Lima, Luciano O Souza, Diego Iglesias-Gato, et al.
European Urology Open Science|August 2, 2021
Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder CancerSophia L Maibom, Martin A Røder, Alicia M Poulsen, et al.
BJU International|October 17, 2021
Open vs robot-assisted radical cystectomy (BORARC): a double-blinded, randomised feasibility studySophia L Maibom, Martin A Røder, Eske K Aasvang, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Prostate|June 9, 2015
The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapyKasper D Berg, Martin A Røder, Frederik B Thomsen, et al.
BJU International|January 30, 2016
The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysisKasper D Berg, Frederik B Thomsen, Camilla Nerstrøm, et al.
Urology|November 28, 2021
Long-Term Renal Function Following Radical Cystectomy for Bladder CancerMaja Vejlgaard, Sophia L Maibom, Hein V Stroomberg, et al.
Biomarkers in Medicine|January 15, 2016
Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early resultsSolvej Lippert, Kasper D Berg, Gunilla Høyer-Hansen, et al.
Cancer|May 4, 2018
Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohortsJohn T Helgstrand, Martin A Røder, Nina Klemann, et al.
Cancers|April 3, 2021
Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic ResistanceThiago S Lima, Diego Iglesias-Gato, Luciano D O Souza, et al.
Frontiers in Pharmacology|June 20, 2022
Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate CancerThiago S Lima, Luciano O Souza, Diego Iglesias-Gato, et al.
European Urology Open Science|August 2, 2021
Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder CancerSophia L Maibom, Martin A Røder, Alicia M Poulsen, et al.
BJU International|October 17, 2021
Open vs robot-assisted radical cystectomy (BORARC): a double-blinded, randomised feasibility studySophia L Maibom, Martin A Røder, Eske K Aasvang, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
Pageof 2